Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elia Moreno-Cubero

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
World Journal of Gastroenterology|September 9, 2016
Specific CD8(+) T cell response immunotherapy for hepatocellular carcinoma and viral hepatitisElia Moreno-Cubero, Juan-Ramón Larrubia
Frontiers in Cellular and Infection Microbiology|August 28, 2020
Harnessing Natural Killer Cell Innate and Adaptive Traits in HIV InfectionAljawharah Alrubayyi, Ane Ogbe, Elia Moreno Cubero, et al.
World Journal of Gastroenterology|April 3, 2015
Hepatitis C virus-specific cytotoxic T cell response restoration after treatment-induced hepatitis C virus controlJuan-Ramón Larrubia, Elia Moreno-Cubero, Joaquín Miquel, et al.
Frontiers in Immunology|July 22, 2022
Functional Restoration of Exhausted CD8 T Cells in Chronic HIV-1 Infection by Targeting Mitochondrial DysfunctionAljawharah Alrubayyi, Elia Moreno-Cubero, Dan Hameiri-Bowen, et al.
Frontiers in Immunology|March 6, 2020
Subordinate Effect of -21M HLA-B Dimorphism on NK Cell Repertoire Diversity and Function in HIV-1 Infected Individuals of African OriginElia Moreno Cubero, Ane Ogbe, Isabela Pedroza-Pacheco, et al.
World Journal of Gastroenterology|May 10, 2018
Is it possible to stop nucleos(t)ide analogue treatment in chronic hepatitis B patients?Elia Moreno-Cubero, Robert T Sánchez Del Arco, Julia Peña-Asensio, et al.
World Journal of Gastroenterology|April 8, 2014
Adaptive immune response during hepatitis C virus infectionJuan Ramón Larrubia, Elia Moreno-Cubero, Megha Uttam Lokhande, et al.
Therapeutic Advances in Gastroenterology|August 21, 2025
Defining partial response in inflammatory bowel disease: a Delphi consensus and economic evaluationIago Rodríguez-Lago, Luis Menchén, José Germán Sánchez-Hernández, et al.
Journal of Virology|November 3, 2017
According to Hepatitis C Virus (HCV) Infection Stage, Interleukin-7 Plus 4-1BB Triggering Alone or Combined with PD-1 Blockade Increases TRAF1<sup>low</sup> HCV-Specific CD8<sup>+</sup> Cell ReactivityElia Moreno-Cubero, Dolores Subirá, Eduardo Sanz-de-Villalobos, et al.
Cellular Immunology|November 30, 2013
HCV-specific CD8+ cell detection at week 12 of chronic hepatitis C treatment with PEG-interferon-α2b/ribavirin correlates with infection resolutionJuan-Ramón Larrubia, Megha-Uttam Lokhande, Elia Moreno-Cubero, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
World Journal of Gastroenterology|September 9, 2016
Specific CD8(+) T cell response immunotherapy for hepatocellular carcinoma and viral hepatitisElia Moreno-Cubero, Juan-Ramón Larrubia
Frontiers in Cellular and Infection Microbiology|August 28, 2020
Harnessing Natural Killer Cell Innate and Adaptive Traits in HIV InfectionAljawharah Alrubayyi, Ane Ogbe, Elia Moreno Cubero, et al.
World Journal of Gastroenterology|April 3, 2015
Hepatitis C virus-specific cytotoxic T cell response restoration after treatment-induced hepatitis C virus controlJuan-Ramón Larrubia, Elia Moreno-Cubero, Joaquín Miquel, et al.
Frontiers in Immunology|July 22, 2022
Functional Restoration of Exhausted CD8 T Cells in Chronic HIV-1 Infection by Targeting Mitochondrial DysfunctionAljawharah Alrubayyi, Elia Moreno-Cubero, Dan Hameiri-Bowen, et al.
Frontiers in Immunology|March 6, 2020
Subordinate Effect of -21M HLA-B Dimorphism on NK Cell Repertoire Diversity and Function in HIV-1 Infected Individuals of African OriginElia Moreno Cubero, Ane Ogbe, Isabela Pedroza-Pacheco, et al.
World Journal of Gastroenterology|May 10, 2018
Is it possible to stop nucleos(t)ide analogue treatment in chronic hepatitis B patients?Elia Moreno-Cubero, Robert T Sánchez Del Arco, Julia Peña-Asensio, et al.
World Journal of Gastroenterology|April 8, 2014
Adaptive immune response during hepatitis C virus infectionJuan Ramón Larrubia, Elia Moreno-Cubero, Megha Uttam Lokhande, et al.
Therapeutic Advances in Gastroenterology|August 21, 2025
Defining partial response in inflammatory bowel disease: a Delphi consensus and economic evaluationIago Rodríguez-Lago, Luis Menchén, José Germán Sánchez-Hernández, et al.
Journal of Virology|November 3, 2017
According to Hepatitis C Virus (HCV) Infection Stage, Interleukin-7 Plus 4-1BB Triggering Alone or Combined with PD-1 Blockade Increases TRAF1<sup>low</sup> HCV-Specific CD8<sup>+</sup> Cell ReactivityElia Moreno-Cubero, Dolores Subirá, Eduardo Sanz-de-Villalobos, et al.
Cellular Immunology|November 30, 2013
HCV-specific CD8+ cell detection at week 12 of chronic hepatitis C treatment with PEG-interferon-α2b/ribavirin correlates with infection resolutionJuan-Ramón Larrubia, Megha-Uttam Lokhande, Elia Moreno-Cubero, et al.
Pageof 2